(19)
(11)
EP 1 404 698 A2
(12)
(88)
Date of publication A3:
17.04.2003
(43)
Date of publication:
07.04.2004
Bulletin 2004/15
(21)
Application number:
02742241.9
(22)
Date of filing:
19.06.2002
(51)
International Patent Classification (IPC)
7
:
C07H
21/02
,
C07H
21/04
,
A61K
48/00
,
C12Q
1/68
,
C12N
15/85
,
C12N
15/86
,
C12P
19/34
(86)
International application number:
PCT/US2002/019664
(87)
International publication number:
WO 2003/000707
(
03.01.2003
Gazette 2003/01)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
21.06.2001
US 888360
(71)
Applicant:
ISIS PHARMACEUTICALS, INC.
Carlsbad, CA 92008 (US)
(72)
Inventors:
BENNETT, Frank, C.
Carlsbad, CA 92008 (US)
DOBIE, Kenneth
Del Mar, CA 92014 (US)
(74)
Representative:
Hallybone, Huw George et al
Carpmaels and Ransford,43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)
(54)
ANTISENSE MODULATION OF SUPEROXIDE DISMUTASE 1, SOLUBLE EXPRESSION